Feb 2020 @auManufacturing

sleep deviceHearing implant group Cochlear has increased its investment in a start-up business developing a device to combat obstructive sleep apnea. Apnea, a market dominated by Cochlear’s Australian rival ResMed, has attracted a number of competing devices with healthcare company Nyxoah pursuing a novel approach.

The company’s device (pictured) stimulates the tongue nerve during sleep, triggering the nerve to contract the tongue. A minimally invasive surgical procedure to implant a neurostimulator is part of the treatment. Cochlear first invested 13 million Euros in Nyxoah in 2018 which has been revalued at $35.8 million. Now the Sydney company has invested a further $13 million as part of a much larger round of funding. Cochlear made the investments through its innovation fund.

Upcoming Events

Mon Tue Wed Thu Fri Sat Sun
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

Become a Member

Become a Cicada member
For only A$10 for life, you will receive a copy of Buzz magazine and can attend events.

Latest News

Deafblindness

Here is a link to Deafblindness support and information.
They are based in Western Australia and supported by Senses Australia.

Hear For You logo

 

 

 

Hear For You web site

Vision Statement: “For all young people who are deaf to reach their potential in life.”

Go to top
JSN Boot template designed by JoomlaShine.com
Web Analytics